Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective

By  

Current Drug Metabolism, Vol. 13, Iss. 3, 2012-03 ,pp. : 284-305

Bentham Science Publishers

Access to resources Recommend Favorite

NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWAN

By Lin Pinpin   Wang Hsiu-Jen   Lee Huei   Lee Hong-Shen   Wang Shu-Li   Hsueh Yu-Mei   Tsai Kan-Jen   Chen Chih-Yi  

Journal of Toxicology and Environmental Health, Vol. 58, Iss. 4, 1999-10 ,pp. : 187-197

Taylor & Francis Ltd

Access to resources Recommend Favorite

A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

By Schelman William   Mohammed Tabraiz   Traynor Anne   Kolesar Jill   Marnocha Rebecca   Eickhoff Jens   Keppen Michael   Alberti Dona   Wilding George   Takebe Naoko   Liu Glenn  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 295-302

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors

By Danesi Romano   Altavilla Giuseppe   Giovannetti Elisa   Rosell Raffael  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 69-80

Future Medicine

Access to resources Recommend Favorite

Small Cell Lung Cancer in Elderly Patients: A Review

By Owonikoko Taofeek K.   Ramalingam Suresh  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 333-344

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite